drugset / Trial / NCT00003611

Acitretin in Preventing Skin Cancers in Patients With Previously Treated Skin Cancers Who Have Undergone Organ Transplantation

NCT00003611

RandomizedParallel-groupDouble-blindPrevention

Summary

RATIONALE: Chemoprevention therapy is the use of certain drugs to try to prevent the development or recurrence of cancer. The use of acitretin may be an effective way to prevent the recurrence or further development of skin cancer. PURPOSE: Randomized clinical trial to study the effectiveness of acitretin in preventing skin cancers in patients with at least two previously treated skin cancers who have undergone organ transplantation.

Timeline

Start
2000-05
Primary completion
2003-02
Completion
2003-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Acitretin Small molecule 25 mg Oral